Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
397 studies found for:    "Emtricitabine"[TREATMENT] AND HIV [CONDITION]
Show Display Options
Download search resultsDownload the search results for:
"Emtricitabine"[TREATMENT] AND HIV [CONDITION] (397 records)
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Recruiting Bone Mineral Density Changes in HIV-positive Females With Osteopenia Switching to Raltegravir
Conditions: HIV Infection;   Osteopenia
Interventions: Drug: raltegravir and atazanavir and ritonavir;   Drug: tenofovir/emtricitabine and atazanavir and ritonavir
2 Completed An Open-Label Study of Emtricitabine in Combination With Other Antiretroviral Agents in HIV Infected Pediatric Subjects
Condition: HIV Infections
Intervention: Drug: Emtricitabine
3 Completed Treatment of Acute HIV With Emtricitabine, Tenofovir and Efavirenz (CID 0805)
Conditions: Acute HIV Infection;   HIV Infections
Intervention: Drug: Atripla
4 Withdrawn Raltegravir Activity In Lymphoid Tissues
Conditions: HIV Infection;   HIV Infections
Interventions: Drug: Efavirenz + Tenofovir DF/Emtricitabine;   Drug: Raltegravir + Tenofovir DF/Emtricitabine;   Procedure: Colonoscopy with biopsies;   Procedure: Inguinal Lymph Node Excision
5 Unknown  Emtricitabine Given Once A Day With Other Anti-HIV Drugs in Children With HIV
Condition: HIV Infections
Interventions: Drug: Lopinavir/Ritonavir;   Drug: Emtricitabine;   Drug: Stavudine
6 Unknown  Pharmacokinetics of Emtricitabine/Tenofovir/Efavirenz in HIV-infected Patients With Tuberculosis
Conditions: Tuberculosis;   HIV Infections
Intervention: Drug: Emtricitabine/tenofovir/efavirenz
7 Completed Efficacy of Tenofovir-Emtricitabine and Efavirenz in HIV Infected Patients With Tuberculosis (ANRS129)
Conditions: HIV Infections;   Tuberculosis
Interventions: Drug: efavirenz;   Drug: tenofovir DF;   Drug: emtricitabine
8 Completed Efficacy of Treatment Intensification With Maraviroc on HIV-1 Viral Latency in Recently Infected Hiv-1 naïve Patients Starting Raltegravir Plus Tenofovir/Emtricitabine
Condition: HIV Infections
Interventions: Drug: Raltegravir;   Drug: Maraviroc;   Drug: Tenofovir/Emtricitabine
9 Active, not recruiting Evaluation of Three Strategies of Second-line Antiretroviral Treatment in Africa (Dakar - Bobo-Dioulasso - Yaoundé)
Conditions: HIV;   HIV Infections
Interventions: Drug: emtricitabine/tenofovir + lopinavir/ritonavir (WHO recommended second line);   Drug: abacavir + didanosine + lopinavir/ritonavir (WHO recommended second line);   Drug: emtricitabine/tenofovir + darunavir + ritonavir (Second line strategy under evaluation)
10 Completed Study Comparing Two Alternatives of Antiretroviral Therapy as Post-exposure Prophylaxis to HIV-1: Tenofovir + Emtricitabine + Lopinavir/Ritonavir Versus Tenofovir + Emtricitabine + Raltegravir (RAL-PEP)
Condition: HIV Infection
Interventions: Drug: Tenofovir, Emtricitabine, Lopinavir/r;   Drug: Tenofovir, Emtricitabine, Raltegravir
11 Completed
Has Results
Raltegravir + Lopinavir/Ritonavir or Emtricitabine/Tenofovir for HIV Treatment Naive Subjects
Condition: HIV Infections
Interventions: Drug: Raltegravir & Lopinavir/ritonavir;   Drug: Raltegravir and emtricitabine/tenofovir
12 Completed Efficacy and Tolerance of Peg-interferon Alpha 2a Added to Tenofovir and Emtricitabine in AgHBe Positive HBV-HIV Co-infected Patients
Conditions: Hepatitis B;   HIV Infections
Interventions: Drug: TRUVADA (EMTRICITABINE + TENOFOVIR DF);   Biological: PEGASYS 180μg (Interféron pégylé alpha -2a)
13 Completed Evaluation of the Cellular Pharmacology of Tenofovir and Emtricitabine According to HIV Infection Status
Condition: HIV Infections
Interventions: Drug: Emtricitabine (FTC);   Drug: Tenofovir disoproxil fumarate (TDF);   Drug: Efavirenz (EFV);   Drug: Truvada
14 Completed Safety of Tenofovir Disoproxil Fumarate (TDF) and Emtricitabine/TDF in HIV Infected Pregnant Women and Their Infants
Condition: HIV Infections
Interventions: Drug: Emtricitabine/Tenofovir disoproxil fumarate;   Drug: Tenofovir disoproxil fumarate
15 Completed Emtricitabine/Tenofovir Disoproxil Fumarate for HIV Prevention in Men
Condition: HIV Infections
Interventions: Drug: Emtricitabine/tenofovir disoproxil fumarate;   Drug: Placebo
16 Completed Evaluating the Safety and Tolerability of Antiretroviral Drug Regimens Used as Pre-Exposure Prophylaxis to Prevent HIV Infection in At-Risk Men Who Have Sex With Men and in At-Risk Women
Condition: HIV Infection
Interventions: Drug: Maraviroc;   Drug: Emtricitabine;   Drug: Tenofovir disoproxil fumarate;   Other: Maraviroc placebo;   Other: Emtricitabine placebo;   Other: Tenofovir disoproxil fumarate placebo
17 Completed Efficacy of Tenofovir and Emtricitabine in ARV-naive Patients With HIV/HBV Co-infection
Conditions: Hepatitis B Virus;   HIV Infections
Intervention: Drug: Emtricitabine
18 Completed
Has Results
Pre-Exposure Prophylaxis to Prevent HIV-1 Acquisition Within HIV-1 Discordant Couples
Conditions: HIV-1 Infections;   HIV Infections
Interventions: Drug: Tenofovir Disoproxil Fumarate (TDF);   Drug: Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF);   Drug: Placebo
19 Completed Study of Viral Load Decay Rates in HIV Infected Participants Starting Treatment With Raltegravir (RAL) and Emtricitabine/Tenofovir Disoproxil Fumarate (TDF)
Condition: HIV Infections
Interventions: Drug: Raltegravir;   Drug: Emtricitabine/tenofovir disoproxil fumarate
20 Completed
Has Results
Determining the Effects of Observed and Self-Administered Drug Regimens in HIV Infected Adults
Condition: HIV Infections
Interventions: Drug: Lopinavir/ritonavir;   Drug: Emtricitabine/Tenofovir disoproxil fumarate;   Drug: Tenofovir disoproxil fumarate;   Drug: Zidovudine;   Drug: Emtricitabine

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years